Intuitive Surgical CEO Sells Shares Worth 20 Billion Won Including Children's Trust

On January 27, Gary S. Guthart, CEO of Intuitive Surgical, exercised 25,500 non-qualified stock options to acquire the same number of common shares. Under a pre-established Rule 10b5-1 trading plan, he then sold 24,500 shares at approximately $530 each, generating about $13 million. That same day, he also sold 2,800 shares held in a trust for his children, netting roughly $1.5 million, while maintaining total direct and indirect holdings of about 1.26 million shares.

On the same date, Chief Medical Officer Myriam Curet exercised 230 non-qualified stock options in two tranches and sold all shares acquired. Between February 10 and 11, she sold a portion of the shares obtained through restricted stock unit (RSU) vesting and option exercises, along with several hundred existing shares, under a Rule 10b5-1 plan. She used additional RSU shares to cover tax withholding and continues to hold several hundred shares in a trust, as well as unvested RSUs and options.

In its preliminary results for the fourth quarter of fiscal 2025, announced on January 22, Intuitive Surgical reported revenue of approximately $2.87 billion, up 19% year-over-year. Full-year 2025 revenue rose 21% to about $10.06 billion. Annual da Vinci surgical procedure volume reached roughly 3.15 million cases, and the company projects global da Vinci case growth of 13–15% in 2026.

Intuitive Surgical, headquartered in Sunnyvale, California, is a leader in robot-assisted minimally invasive surgery. The company supplies hospitals worldwide with surgical robots and instruments—including the da Vinci Surgical System and the Ion endoluminal system—alongside services and training programs, and continues to drive innovation in the robotic surgery market.